Try our beta test site
170 studies found for:    Open Studies | "Mycoses"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Mycoses"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
Condition: Mycosis Fungoides
Interventions: Biological: A-dmDT390-bisFv(UCHT1);   Drug: Vorinostat
2 Not yet recruiting Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method
Condition: Mycoses
Intervention:
3 Recruiting Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Intervention: Drug: Valchlor
4 Recruiting TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Conditions: Mycosis Fungoides;   Sézary Syndrome
Interventions: Radiation: TSEB Therapy;   Drug: Brentuximab vedotin
5 Not yet recruiting Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
Conditions: Mycosis Fungoides;   Cutaneous T-cell Lymphoma
Interventions: Radiation: Total skin electron beam therapy (TSEBT);   Drug: mechlorethamine gel 0.016%
6 Recruiting Fungiscope - A Global Emerging Fungal Infection Registry
Condition: Invasive Fungal Disease
Intervention:
7 Recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Non-Hodgkin's Lymphoma
Intervention:
8 Recruiting Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides
Conditions: Recurrent Mycosis Fungoides;   Refractory Mycosis Fungoides;   Stage I Mycosis Fungoides;   Stage II Mycosis Fungoides;   Stage III Mycosis Fungoides
Interventions: Other: Quality-of-Life Assessment;   Other: Objective Grading of Skin Findings
9 Recruiting Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
Condition: Invasive Fungal Infections
Intervention: Other: Peripheral blood sampling
10 Recruiting Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
Conditions: Mycosis Fungoides;   Sezary Syndrome;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: resminostat;   Drug: Placebo
11 Not yet recruiting Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome
Condition: Mycoses
Intervention:
12 Recruiting Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype
Conditions: Cutaneous T-cell Lymphoma (CTCL);   Mycosis Fungoides
Intervention: Drug: MRG-106
13 Recruiting Effect of Inflammation on Pharmacokinetics of Posaconazole
Condition: Mycoses
Intervention: Drug: posaconazole
14 Recruiting Naloxone Hydrochloride Study for Relief of Pruritus in Patients With Mycosis Fungoides (MF) Form of CTCL
Conditions: Mycosis Fungoides;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: Naloxone Hydrochloride Lotion, 0.5%;   Drug: Placebo Lotion
15 Not yet recruiting Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Interventions: Drug: 3.75% Imiquimod Cream;   Drug: 0.1% Fluocinonide Cream
16 Recruiting MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
Condition: Fungal Infection
Intervention: Drug: Voriconazole
17 Recruiting Early Diagnosis of Mycosis Fungoides
Condition: Cutaneous T Cell Lymphoma
Intervention: Other: Blood sampling
18 Recruiting Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Condition: Fungal Infection
Interventions: Drug: APX001 single IV dose;   Drug: APX001 single oral dose 1;   Drug: APX001 single oral dose 2;   Drug: APX001 single oral dose 3;   Drug: APX001 single oral dose fasted;   Drug: APX001 single oral dose fed;   Drug: APX001 multiple oral doses 1;   Drug: APX001 multiple oral doses 2;   Drug: APX001 multiple oral doses 3;   Drug: Cytochrome P450 substrates;   Drug: Matching placebo control
19 Recruiting Safety, Tolerability and Pharmacokinetics of APX001 Administered Intravenously
Condition: Fungal Infection
Interventions: Drug: APX001 single dose 1;   Drug: APX001 single dose 2;   Drug: APX001 single dose 3;   Drug: APX001 single dose 4;   Drug: APX001 single dose 5;   Drug: APX001 single dose 6;   Drug: APX001 multiple dose 1;   Drug: APX001 multiple dose 2;   Drug: APX001 multiple dose 3;   Drug: APX001 multiple dose 4;   Drug: Matching Placebo
20 Recruiting Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Condition: Fungal Infections
Intervention: Drug: Posaconazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.